TrialsgrambetaRCTs are beautiful

NINDS rt-PA

1995

Tissue Plasminogen Activator for Acute Ischemic Stroke

In 624 patients with acute ischaemic stroke within 3 h, intravenous alteplase 0.9 mg/kg improved functional outcome at 3 months versus placebo.

Result

Efficacy: Favourable functional outcome at 90 daysOR 1.7 (95% CI 1.2-2.6) · P = 0.008

Below 1 favours placebo, above 1 favours intravenous alteplase 0.9 mg/kg.

Also reported: Symptomatic ICH 6.4% vs 0.6%.

Original publication
Subtopic
IV thrombolysis
Design
Double-blind RCT, NIH
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
The NINDS rt-PA Stroke Study Group. N Engl J Med. 1995;333(24):1581-1587.doi 10.1056/NEJM199512143332401

Discussion & critique

Founding trial of IV thrombolysis; ICH risk shaped patient selection and quality metrics for two decades.

Discussed in podcasts